Patents by Inventor Richard T. McCarthy

Richard T. McCarthy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LED Multidimensional Printed Wiring Board Using Standoff Boards
    Publication number: 20090073713
    Abstract: A substrate assembly for use in a lamp has a main printed wiring board and a standoff board. The main printed wiring board has a main surface with one or more LED packages disposed on the main surface and electrically connected thereto. The standoff board is disposed on the main surface of the main printed wiring board. The standoff board has an LED package disposed thereon and conductors to provide an electrical connection between the LED package disposed on the standoff board and the main printed wiring board.
    Type: Application
    Filed: September 7, 2007
    Publication date: March 19, 2009
    Inventors: Andrew Z. Glovatsky, Steven D. McCarthy, Richard T. McCarthy, Joseph Binetti, Donald Pope
  • Bis-(quinolyl)-diamines
    Patent number: 6174897
    Abstract: The present invention relates to bis-(quinolyl)-diamines of the general formula (I): in which the indicated substituents are as defined in the description. The invention also provides a process for the preparation of the compounds of the formula (I), their use for the preparation of drugs, and drugs containing said compounds.
    Type: Grant
    Filed: October 25, 1996
    Date of Patent: January 16, 2001
    Assignee: Bayer Aktiengesellschaft
    Inventors: Rudolf Schohe-Loop, Peter-Rudolf Seidel, William Bullock, Achim Feurer, Georg Terstappen, Joachim Schuhmacher, Franz-Josef van der Staay, Bernard Schmidt, Richard J. Fanelli, Jane C. Chisholm, Richard T. McCarthy
  • 2,2'-bridged bis-2,4-diaminoquinazolines
    Patent number: 5874438
    Abstract: The present invention relates to 2,2'-bridged bis-2,4-diaminoquinazolines of the general formula (I): ##STR1## in which the indicated substituents are as defined in the description. The invention also provides processes for the preparation of the compounds of the formula (I), their use for the preparation of drugs, and drugs containing said compounds.
    Type: Grant
    Filed: October 11, 1996
    Date of Patent: February 23, 1999
    Assignee: Bayer Aktiengesellschaft
    Inventors: Rudolf Schohe-Loop, Peter-Rudolf Seidel, William Bullock, Walter Hubsch, Achim Feurer, Hans-Georg Lerchen, Georg Terstappen, Joachim Schuhmacher, Franz-Josef van der Staay, Bernard Schmidt, Richard J. Fanelli, Jane C. Chisholm, Richard T. McCarthy
  • Ring-bridged bis-quinolines
    Patent number: 5866562
    Abstract: The present invention relates to ring-bridged bis-quinolines of the general formula (I): ##STR1## in which the indicated substituents are as defined in the description. The invention also provides a process for the preparation of compounds of the formula (I), their use for the preparation of drugs, and drugs containing said compounds.
    Type: Grant
    Filed: October 25, 1996
    Date of Patent: February 2, 1999
    Assignee: Bayer Aktiengesellschaft
    Inventors: Rudolf Schohe-Loop, Peter-Rudolf Seidel, William Bullock, Achim Feurer, Georg Terstappen, Joachim Schuhmacher, Franz-Josef van der Staay, Bernard Schmidt, Richard J. Fanelli, Jane C. Chisholm, Richard T. McCarthy
  • 4, 4'-bridged bis-2, 4-diaminoquinazolines
    Patent number: 5760230
    Abstract: 4,4'-Bridged bis-2,4-diaminoquinazolines of the general formula (I) ##STR1## processes for their preparation and use as agents acting on the potassium channels of the brain.
    Type: Grant
    Filed: October 11, 1996
    Date of Patent: June 2, 1998
    Assignee: Bayer Aktiengesellschaft
    Inventors: Rudolf Schohe-Loop, Peter-Rudolf Seidel, William Bullock, Achim Feurer, Hans-Georg Lerchen, Georg Terstappen, Joachim Schuhmacher, Franz-Josef van der Staay, Bernard Schmidt, Richard J. Fanelli, Jane C. Chisholm, Richard T. McCarthy
  • Use of bisquinoline compounds in the treatment of cerebral disorders
    Patent number: 5756517
    Abstract: The present invention relates to the use of bisquinolines of the general formula ##STR1## in which the substituents mentioned have the meanings given in the description.The invention furthermore relates to new bisquinolines of the general formula (I), to a process for the preparation of the known and the new bisquinolines, to the use of the new bisquinolines as medicaments, to their use for the preparation of medicaments, and to medicaments comprising them.
    Type: Grant
    Filed: October 25, 1996
    Date of Patent: May 26, 1998
    Assignee: Bayer Aktiengesellschaft
    Inventors: Rudolf Schohe-Loop, Peter-Rudolf Seidel, William Bullock, Achim Feurer, Georg Terstappen, Joachim Schuhmacher, Franz-Josef van der Staay, Bernard Schmidt, Richard J. Fanelli, Jane C. Chisholm, Richard T. McCarthy
  • 2,4'-bridged bis-2,4-diaminoquinazolines
    Patent number: 5739127
    Abstract: The present invention provides 2,4'-bridged bis-2,4-diaminoquinazolines of the general formula (I): ##STR1## in which the indicated substituents are as defined in the description. The invention also provides a process for the preparation of the compounds of the formula (I), drugs containing said compounds and processes for the preparation of drugs containing said compounds.
    Type: Grant
    Filed: November 8, 1996
    Date of Patent: April 14, 1998
    Assignee: Bayer Aktiengesellschaft
    Inventors: Rudolf Schohe-Loop, Peter-Rudolf Seidel, William Bullock, Gabriele Handke, Achim Feurer, Wolfgang Roben, Georg Terstappen, Joachim Schuhmacher, Franz-Josef van der Staay, Bernard Schmidt, Richard J. Fanelli, Jane C. Chisholm, Richard T. McCarthy